Hurley John Joseph 4

What Happened John Joseph Hurley, Principal Accounting Officer of Avanos Medical, received an award of 2,211 restricted share units (reported as an acquisition) on March 13, 2026. The units were granted at $0.00 per unit (an equity award rather than a cash purchase). This is a grant of TRSUs under the company's long‑term incentive plan, not a sale or open‑market purchase.

Key Details

• Transaction date: March 13, 2026; filing date: March 17, 2026 (filed within required Form 4 timeframe).
• Transaction type/code: A — Grant/Award (2,211 units) at $0.00 per unit.
• Vesting/footnote: F1 — These are time‑based restricted share units (TRSUs). Vesting is 1/3 on Mar 13, 2027, 1/3 on Mar 13, 2028, and 1/3 on Mar 13, 2029. Each TRSU is economically equivalent to one share of common stock.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• No 10b5‑1 plan, tax‑withholding, or immediate sale noted in the filing.

Context Time‑based RSU/TRSU grants are common executive compensation and represent future equity if the officer remains employed and vesting conditions are met. Because these units vest over multiple years and were not sold upon vesting, they do not indicate an immediate buy or sell signal by the insider.